A groundbreaking sleep apnea treatment has emerged with a remarkable 93% success rate, offering hope to millions worldwide. This innovative approach, developed by researchers at Flinders University in Australia, builds upon an existing treatment called hypoglossal nerve stimulation (HNS), which uses electrical pulses to prevent the tongue from blocking the throat during sleep.
However, the current HNS method requires surgery and a bulky implant, making it invasive and time-consuming. Researchers aimed to create a smaller, more manageable electrode, and their efforts paid off. In brief stimulation trials, the new HNS electrode successfully opened the airway in 13 out of 14 participants, even in cases where breathing had stopped.
Otolaryngologist Simon Carney describes the procedure as "a 90-minute process with minimal discomfort." Importantly, it worked for patients previously deemed unsuitable for HNS.
While further development and testing are needed, this new HNS treatment promises a less invasive, clinic-based option with reduced recovery time. It could be a game-changer for those with obstructive sleep apnea (OSA), offering a more comfortable and effective alternative to the current first-line treatment, Continuous Positive Airway Pressure (CPAP), which involves wearing a mask during sleep.
Physiologist and lead author Amal Osman highlights the potential benefits: "This approach may reduce recovery time and costs while improving success rates for those who cannot tolerate conventional treatments."
The team plans to integrate their technique with wearable technologies and explore targeting other nerves and muscles to enhance airflow. Although the study was conducted in a sleep lab with a small group, the initial findings are highly promising.
OSA is a serious condition, disrupting sleep and increasing the risk of cardiovascular disease and dementia. Improved treatments like this new HNS version could significantly impact the lives of those affected.
Danny Eckert from Flinders University sums it up: "Our goal is to provide better choices and outcomes. This study showcases how innovation can make sleep apnea treatment more accessible, comfortable, and effective."
The research has been published in Chest, offering a promising glimpse into the future of sleep apnea treatment.
